Alcohol Consumption Impacts Liver Fibrosis Progression in Minority of Patients Screened for Hepatitis C at Drug Treatment Centers
Open Access
- 1 March 2025
- journal article
- Published by SAGE Publications in Substance Use: Research and Treatment
- Vol. 19
Abstract
Background & Aims: Hepatitis C virus (HCV) infection is a prevalent disease at drug treatment centers (DTC). Alcohol abuse may also contribute to liver fibrosis at DTC, which may affect the prescription of HCV therapy. This study evaluated the risk of alcohol intake and other predictive factors for fibrosis progression. Methods: An on-site dried-blood-spot (DBS) testing program for hepatitis C care at DTC from 2017 to 2019 was used to identify patients with previous HCV-antibody testing and fibrosis score data. Patients were grouped based on RNA status, alcohol intake and advanced liver disease (ALD ⩾ F3). Fibrosis progression was assessed using APRI and FIB-4. Kaplan-Meier and Cox-regression analyses were performed. Results: Positive HCV RNA patients (n = 138) exhibited a higher rate of ALD (11% vs 2.2%, P < .001) and a higher risk of fibrosis progression during follow-up (HR = 3.14, 95% CI: 1.2-8.2) than patients who did not have an infection (n = 230). Overall, 25% (n = 84) reported high-risk alcohol consumption, which was associated with an increased risk of ALD in patients with RNA positivity (HR = 3.2; 95% CI: 1.1-9.1). Alcohol consumption at any dose regardless of HCV infection status was not associated with ALD. Age, high-risk alcohol consumption, and RNA positivity were independent factors for progression to ALD. Conclusions: Patients with active HCV infections at DTC have an increased risk for ALD compared to patients without HCV. High-risk alcohol consumption is present in a minority of patients aggravating fibrosis. These results suggest that HCV treatment should not be delayed at DTC regardless of alcohol consumption.Keywords
Funding Information
- European Regional Development Fund
- Instituto de Salud Carlos III (PI19/01756)
This publication has 37 references indexed in Scilit:
- Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver diseaseComparative Hepatology, 2012
- Hepatitis C virus infection among drug addicts in ItalyJournal of Medical Virology, 2012
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menHepatology, 2011
- Independent and Additive Interactive Effects Among Tumor Necrosis Factor-α Polymorphisms, Substance Use Habits, and Chronic Hepatitis B and Hepatitis C Virus Infection on Risk for Hepatocellular CarcinomaMedicine, 2009
- Natural Course of Chronic HCV and HBV Infection and Role of Alcohol in the General Population: The Dionysos StudyAmerican Journal of Gastroenterology, 2008
- Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trialJournal of Viral Hepatitis, 2008
- The depiction of stigmatization in research about hepatitis CInternational Journal of Drug Policy, 2007
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- Impact of alcohol on the histological and clinical progression of Hepatitis C infectionHepatology, 1998